SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $880,824 | -96.6% | 42,800 | -87.6% | 0.00% | -96.9% |
| Q1 2021 | $25,823,000 | -71.6% | 345,000 | -67.1% | 0.13% | -76.6% |
| Q4 2020 | $90,836,000 | +41.5% | 1,050,000 | 0.0% | 0.55% | +23.0% |
| Q3 2020 | $64,176,000 | +81.6% | 1,050,000 | +23.5% | 0.44% | +56.9% |
| Q2 2020 | $35,343,000 | +82.3% | 850,000 | +25.9% | 0.28% | +70.5% |
| Q1 2020 | $19,386,000 | -46.3% | 675,000 | +35.0% | 0.17% | -32.0% |
| Q4 2019 | $36,095,000 | -31.0% | 500,000 | +34.1% | 0.24% | -38.2% |
| Q3 2019 | $52,300,000 | -42.9% | 372,800 | -25.4% | 0.40% | -33.6% |
| Q2 2019 | $91,545,000 | -4.1% | 500,000 | -16.7% | 0.60% | -17.1% |
| Q1 2019 | $95,430,000 | +149.1% | 600,000 | +50.0% | 0.72% | +155.5% |
| Q4 2018 | $38,316,000 | -56.6% | 400,000 | -36.0% | 0.28% | -46.1% |
| Q3 2018 | $88,281,000 | -9.8% | 625,000 | 0.0% | 0.52% | -13.7% |
| Q2 2018 | $97,831,000 | +36.5% | 625,000 | +40.4% | 0.60% | +21.8% |
| Q1 2018 | $71,676,000 | +8.8% | 445,000 | +11.2% | 0.50% | -7.3% |
| Q4 2017 | $65,884,000 | +334.3% | 400,000 | +64.3% | 0.54% | +296.3% |
| Q3 2017 | $15,170,000 | +90.5% | 243,500 | +143.5% | 0.14% | +62.7% |
| Q2 2017 | $7,964,000 | – | 100,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |